Mapping lymph flow in oropharyngeal cancer with scans
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study uses a special dye or tracer to map how lymph fluid travels from an oropharyngeal (throat) cancer to nearby lymph nodes. It may help doctors understand the most likely spread pattern and plan future treatment more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a new diagnosis of oropharyngeal cancer (throat cancer)
- Your imaging shows cancer in lymph nodes on one side of the neck (not both sides)
- You have not had prior radiation or surgery to the neck area
- You have no spread to distant parts of the body (like the lungs or bones)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a special scan (SPECT-CT) can guide radiation treatment to only the safer/needed side of the neck in people with a one-sided oropharyngeal cancer. It aims to keep cancer control while potentially reducing side effects from unnecessary radiation.
This trial tests whether using a detailed scan (SPECT) to guide radiation therapy to only one side of the neck works as well as treating both sides. It is for people with oropharyngeal (tonsil, soft palate, or tongue base) cancer that has not spread to the opposite side of the neck.
This study tests an approach called “adaptive radiotherapy,” where the radiation plan may be adjusted based on how your tumor and anatomy look during treatment. It is for adults with biopsy-proven oropharyngeal (throat) squamous cell carcinoma who are planning curative radiation, with or without chemotherapy.
This trial tests if giving less radiation along with chemotherapy is safe and effective for people with HPV-positive throat cancer. It aims to reduce side effects while still controlling the cancer.
This Phase 2 study tests whether removing the tumor through the mouth, followed by a reduced course of radiation, can control HPV-related (p16+) oropharynx throat cancer. It may help reduce treatment intensity after surgery, while still aiming to keep the cancer from coming back.
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
Hear when a new Oropharyngeal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.